These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 28317891

  • 1. Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa).
    Farah BL, Sinha RA, Wu Y, Singh BK, Lim A, Hirayama M, Landau DJ, Bay BH, Koeberl DD, Yen PM.
    Sci Rep; 2017 Mar 20; 7():44408. PubMed ID: 28317891
    [Abstract] [Full Text] [Related]

  • 2. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
    Zhou J, Waskowicz LR, Lim A, Liao XH, Lian B, Masamune H, Refetoff S, Tran B, Koeberl DD, Yen PM.
    Thyroid; 2019 Aug 20; 29(8):1158-1167. PubMed ID: 31337282
    [Abstract] [Full Text] [Related]

  • 3. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
    Farah BL, Landau DJ, Sinha RA, Brooks ED, Wu Y, Fung SYS, Tanaka T, Hirayama M, Bay BH, Koeberl DD, Yen PM.
    J Hepatol; 2016 Feb 20; 64(2):370-379. PubMed ID: 26462884
    [Abstract] [Full Text] [Related]

  • 4. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
    Gjorgjieva M, Calderaro J, Monteillet L, Silva M, Raffin M, Brevet M, Romestaing C, Roussel D, Zucman-Rossi J, Mithieux G, Rajas F.
    J Hepatol; 2018 Nov 20; 69(5):1074-1087. PubMed ID: 30193922
    [Abstract] [Full Text] [Related]

  • 5. Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
    Yavarow ZA, Kang HR, Waskowicz LR, Bay BH, Young SP, Yen PM, Koeberl DD.
    Hum Mol Genet; 2020 Jan 15; 29(2):286-294. PubMed ID: 31816064
    [Abstract] [Full Text] [Related]

  • 6. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y, Hoogerland JA, Bloks VW, Bos T, Bleeker A, Wolters H, Wolters JC, Hijmans BS, van Dijk TH, Thomas R, van Weeghel M, Mithieux G, Houtkooper RH, de Bruin A, Rajas F, Kuipers F, Oosterveer MH.
    Hepatology; 2020 Nov 15; 72(5):1638-1653. PubMed ID: 32083759
    [Abstract] [Full Text] [Related]

  • 7. Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III.
    Jauze L, Monteillet L, Mithieux G, Rajas F, Ronzitti G.
    Hum Gene Ther; 2019 Oct 15; 30(10):1263-1273. PubMed ID: 31319709
    [Abstract] [Full Text] [Related]

  • 8. A detailed characterization of the adult mouse model of glycogen storage disease Ia.
    Salganik SV, Weinstein DA, Shupe TD, Salganik M, Pintilie DG, Petersen BE.
    Lab Invest; 2009 Sep 15; 89(9):1032-42. PubMed ID: 19581879
    [Abstract] [Full Text] [Related]

  • 9. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas.
    Mutel E, Abdul-Wahed A, Ramamonjisoa N, Stefanutti A, Houberdon I, Cavassila S, Pilleul F, Beuf O, Gautier-Stein A, Penhoat A, Mithieux G, Rajas F.
    J Hepatol; 2011 Mar 15; 54(3):529-37. PubMed ID: 21109326
    [Abstract] [Full Text] [Related]

  • 10. Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia.
    Waskowicz LR, Zhou J, Landau DJ, Brooks ED, Lim A, Yavarow ZA, Kudo T, Zhang H, Wu Y, Grant S, Young SP, Huat BB, Yen PM, Koeberl DD.
    Hum Mol Genet; 2019 Jan 01; 28(1):143-154. PubMed ID: 30256948
    [Abstract] [Full Text] [Related]

  • 11. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
    Monteillet L, Gjorgjieva M, Silva M, Verzieux V, Imikirene L, Duchampt A, Guillou H, Mithieux G, Rajas F.
    Mol Metab; 2018 Oct 01; 16():100-115. PubMed ID: 30100243
    [Abstract] [Full Text] [Related]

  • 12. Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria?
    Rossi A, Ruoppolo M, Formisano P, Villani G, Albano L, Gallo G, Crisci D, Moccia A, Parenti G, Strisciuglio P, Melis D.
    J Inherit Metab Dis; 2018 Nov 01; 41(6):985-995. PubMed ID: 29435782
    [Abstract] [Full Text] [Related]

  • 13. Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review.
    Cho JH, Weinstein DA, Lee YM.
    J Inherit Metab Dis; 2021 Jan 01; 44(1):118-128. PubMed ID: 32474930
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
    Clar J, Mutel E, Gri B, Creneguy A, Stefanutti A, Gaillard S, Ferry N, Beuf O, Mithieux G, Nguyen TH, Rajas F.
    Hum Mol Genet; 2015 Apr 15; 24(8):2287-96. PubMed ID: 25561689
    [Abstract] [Full Text] [Related]

  • 16. Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
    Sun MS, Pan CJ, Shieh JJ, Ghosh A, Chen LY, Mansfield BC, Ward JM, Byrne BJ, Chou JY.
    Hum Mol Genet; 2002 Sep 01; 11(18):2155-64. PubMed ID: 12189168
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia.
    Koeberl DD, Sun B, Bird A, Chen YT, Oka K, Chan L.
    Mol Ther; 2007 Jul 01; 15(7):1253-8. PubMed ID: 17505475
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.